REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 144 filers reported holding REVANCE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $371,000 | +64.9% | 15,200 | 0.0% | 0.05% | +35.3% |
| Q1 2020 | $225,000 | -87.8% | 15,200 | -86.6% | 0.03% | -71.9% |
| Q4 2019 | $1,842,000 | +165.4% | 113,544 | +112.6% | 0.12% | +44.0% |
| Q3 2019 | $694,000 | +1.6% | 53,400 | +1.4% | 0.08% | -1.2% |
| Q2 2019 | $683,000 | -23.5% | 52,672 | -7.1% | 0.08% | -30.3% |
| Q1 2019 | $893,000 | -21.7% | 56,672 | 0.0% | 0.12% | -23.3% |
| Q4 2018 | $1,141,000 | -21.7% | 56,672 | -3.4% | 0.16% | -23.2% |
| Q3 2018 | $1,458,000 | +60.4% | 58,672 | +77.3% | 0.21% | +71.1% |
| Q2 2018 | $909,000 | +224.6% | 33,100 | +263.7% | 0.12% | +236.1% |
| Q1 2018 | $280,000 | -13.8% | 9,100 | 0.0% | 0.04% | -32.1% |
| Q4 2017 | $325,000 | – | 9,100 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NovaQuest Capital Management, L.L.C. | 1,558,426 | $48,000,000 | 65.50% |
| Essex Woodlands Management, Inc. | 3,842,047 | $118,335,000 | 25.90% |
| Rhenman & Partners Asset Management AB | 203,181 | $6,258,000 | 0.77% |
| EAM Global Investors LLC | 44,898 | $1,383,000 | 0.72% |
| Fosun International Ltd | 319,313 | $9,835,000 | 0.62% |
| EAM Investors, LLC | 113,096 | $3,483,000 | 0.58% |
| ArrowMark Colorado Holdings LLC | 1,735,699 | $53,460,000 | 0.53% |
| Perceptive Advisors | 618,957 | $19,064,000 | 0.53% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 111,360 | $3,430,000 | 0.45% |
| Schonfeld Strategic Advisors LLC | 83,700 | $2,578,000 | 0.19% |